Role of lysyl oxidases in pathogenesis of pulmonary emphysema Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017
Lysyl oxidases in idiopathic pulmonary fibrosis: A key participant in collagen I matrix remodelling Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015
Imbalanced type I TGF-β receptor signalling in the pulmonary vasculature: implications for the pathogenesis of bronchopulmonary dysplasia Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007
Gene regulatory roles for lysyl oxidases in the context of BPD Source: International Congress 2017 – Molecular biology of normal and abnormal lung development Year: 2017
Biochemical and functional characterization of lysyl oxidase like 2 (LOXL2) inhibitors Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 804s Year: 2006
The role of connective tissue dysplasia in genesis of bronchiectases Source: Eur Respir J 2007; 30: Suppl. 51, 376s Year: 2007
Detrimental role for matrix metalloprotease-1 in the pathogenesis of pulmonary fibrosis Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017
Role of smoking factor in development of oxidative stress and bronchial obstruction in paople with a connective tissue dysplasia Source: Eur Respir J 2007; 30: Suppl. 51, 46s Year: 2007
Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008
Transglutaminase 2: a new player in bronchopulmonary dysplasia? Source: Eur Respir J 2014; 44: 109-121 Year: 2014
Activity of matrix metalloproteinases and their inhibitor in children with bronchopulmonary dysplasia Source: Annual Congress 2009 - Respiratory physiology in infants and preschool children, in health and disease Year: 2009
A role of matrix metalloproteinases and their inhibitors in the pathogenesis of fibrosis and angiogenesis in lung precancer processes Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010
Inhibition of collagen cross-links by novel LOXL2 selective inhibitors in an in-vitro model of fibroblastic foci of IPF Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016
Modulation of fibroblast phenotype in idiopathic pulmonary fibrosis: Role of Nrf2 Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011
Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
Lipogenic switch of fibroblast to lipofibroblast induce lung regeneration in a model of bronchopulmonary dysplasia Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019
Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200 Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014
Glutathione redox may regulate airway remodelling in asthma affected with VEGF Source: Annual Congress 2009 - Airways remodelling Year: 2009